Lars‐Petter Jelsness‐Jørgensen
Lars‐Petter Jelsness‐Jørgensen publishes mostly in Genetics, Epidemiology and Rheumatology, on topics such as Inflammatory Bowel Disease, Microscopic Colitis and Fibromyalgia and Chronic Fatigue Syndrome Research.
- World rank
- #637,592 of 7,710,434 ranked researchers
- Rank in Norway
- #3,987 of 33,005
- Works
- 99
- Citations
- 2.3k
- Citations per work
- 22.8
What does Lars‐Petter Jelsness‐Jørgensen research?
Lars‐Petter Jelsness‐Jørgensen's work is mostly in Medicine (32%), Biochemistry, Genetics and Molecular Biology (17%), Health Professions (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4444.4%
- Health Sciences3838.7%
- Medicine3232.1%
- Health Professions76.6%
- Life Sciences1716.9%
- 1Genetics17% of their works
- 2Epidemiology14% of their works
- 3Rheumatology7% of their works
- 4General Health Professions7% of their works
- 5Psychiatry and Mental health6% of their works
- 6Gastroenterology5% of their works
Research topics
- Inflammatory Bowel Disease
- Microscopic Colitis
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Rheumatoid Arthritis Research and Therapies
- Gastrointestinal motility and disorders
- Venous Thromboembolism Diagnosis and Management
- Spondyloarthritis Studies and Treatments
- Atrial Fibrillation Management and Outcomes
Which keywords describe Lars‐Petter Jelsness‐Jørgensen's research?
The keywords of their largest research topics: Inflammatory Bowel Disease, Epidemiology, Crohn's Disease, Ulcerative Colitis, Collagenous Colitis, Microscopic Colitis, Treatment and Inflammation.
- Atrial Fibrillation
- Spondyloarthritis
- Venous Thromboembolism
- Irritable Bowel Syndrome
- Rheumatoid Arthritis
- Fibromyalgia
- Inflammation
- Microscopic Colitis
- Ulcerative Colitis
- Epidemiology
- Inflammatory Bowel Disease
- Crohn's Disease
- Collagenous Colitis
- Treatment
- Chronic Fatigue Syndrome
- Biological Therapy
- Gastrointestinal Disorders
- Antithrombotic Therapy
- Ankylosing Spondylitis
- Anticoagulant Therapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Inflammatory Bowel Disease802 topics
- Epidemiology652 topics
- Crohn's Disease481 topic
- Ulcerative Colitis481 topic
- Collagenous Colitis321 topic
- Microscopic Colitis321 topic
- Treatment272 topics
- Inflammation232 topics
- Chronic Fatigue Syndrome171 topic
- Fibromyalgia171 topic
- Biological Therapy121 topic
- Rheumatoid Arthritis121 topic
- Gastrointestinal Disorders111 topic
- Irritable Bowel Syndrome111 topic
- Antithrombotic Therapy101 topic
- Venous Thromboembolism101 topic
- Ankylosing Spondylitis81 topic
- Spondyloarthritis81 topic
- Anticoagulant Therapy71 topic
- Atrial Fibrillation71 topic
Where does Lars‐Petter Jelsness‐Jørgensen work?
Lars‐Petter Jelsness‐Jørgensen's main affiliation in the publication record is Østfold Hospital Trust, Norway.
How many publications and citations does Lars‐Petter Jelsness‐Jørgensen have?
OpenAlex counts 99 works and 2,253 citations for Lars‐Petter Jelsness‐Jørgensen, an h-index of 28, ranking #637,592 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lars‐Petter Jelsness‐Jørgensen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.